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Disulphide formation in the endoplasmic reticulum (ER) is
catalysed by members of the protein disulphide isomerase
(PDI) family. These enzymes can be oxidized by the
ﬂavoprotein ER oxidoreductin 1 (Ero1), which couples
disulphide formation with reduction of oxygen to form
hydrogen peroxide (H2O2). The H2O2 produced can be
metabolized by ER-localized peroxiredoxin IV (PrxIV).
Continuous catalytic activity of PrxIV depends on reduc-
tion of a disulphide within the active site to form a free
thiol, which can then react with H2O2. Here, we demon-
strate that several members of the PDI family are able to
directly reduce this PrxIV disulphide and in the process
become oxidized. Furthermore, we show that altering
cellular expression of these proteins within the ER inﬂu-
ences the efﬁciency with which PrxIV can be recycled. The
oxidation of PDI family members by PrxIV is a highly
efﬁcient process and demonstrates how oxidation by H2O2
can be coupled to disulphide formation. Oxidation of PDI
by PrxIV may therefore increase efﬁciency of disulphide
formation by Ero1 and also allows disulphide formation
via alternative sources of H2O2.
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Introduction
Disulphide formation is an essential modiﬁcation, which
occurs within the endoplasmic reticulum (ER) of eukaryotic
cells. Introduction of native disulphides can be a complex
process, requiring not only oxidation of cysteine residues but
also reduction and isomerization of non-native disulphides
(Jansens et al, 2002). In keeping with this complexity, a
number of oxidoreductases have been identiﬁed, which
catalyse thiol-disulphide exchange reactions within the ER
(Sevier and Kaiser, 2006). Protein disulphide isomerase (PDI)
represents one of the most extensively studied ER oxidore-
ductases and is a member of a family of ER-resident thior-
edoxin-like proteins (Appenzeller-Herzog and Ellgaard,
2008). Around 20 PDI homologues have been described in
mammalian cells, many of which exhibit distinct client-
protein speciﬁcities (Jessop et al, 2009b). PDI-family proteins
possess active sites containing cysteine residues, within a
CXXC motif. Disulphides formed between these cysteine
residues can be exchanged with client proteins leading to
formation of disulphides within the client and reduction of
the PDI-family member (Creighton et al, 1980). Moreover,
disulphide exchange can occur in the opposite direction
allowing the reduction of non-native disulphides within client
proteins with the concomitant oxidation of the PDI-family
member.
To allow continuous transfer of disulphides to client pro-
teins, PDI must be re-oxidized. The oxidation of PDI can be
catalysed by ER oxidoreductin 1 (Ero1) (Pollard et al, 1998;
Frand and Kaiser, 1999). Ero1 can generate disulphides
de novo by transfer of electrons to molecular oxygen, gen-
erating hydrogen peroxide (H2O2) in the process (Tu and
Weissman, 2002; Gross et al, 2006). In higher eukaryotes, the
H2O2 produced by Ero1 can be metabolized by an ER-resident
enzyme peroxiredoxin IV (PrxIV, Prx4) (Tavender et al, 2008;
Tavender and Bulleid, 2010b). The essential catalytic unit of
PrxIV is a dimer with a peroxidatic cysteine residue (Cys124)
in one chain being able to reduce H2O2 generating water and
becoming oxidized to a cysteine sulphenic acid in the pro-
cess. This sulphenylated cysteine subsequently reacts with a
resolving cysteine residue (Cys245) of the partner chain
within the dimeric subunit, leading to formation of an inter-
molecular disulphide. Hence, PrxIV converts the oxidizing
potential of H2O2 into a disulphide bond.
To maintain activity towards H2O2, the interchain disul-
phide within PrxIV needs to be reduced. This reduction is
achieved for other cellular peroxiredoxins by a member of the
thioredoxin family of proteins (Kalinina et al, 2008). It is
presently unknown which enzyme fulﬁls this role in the ER
for PrxIV, although it is clear that a robust reducing system is
present for recycling of the peroxidatic disulphide (Tavender
and Bulleid, 2010b). There are several thioredoxin-like pro-
teins within the ER that could fulﬁl the role of a reductase
with the inevitable consequence that these enzymes would
become oxidized. Hence, the recycling of PrxIV could provide
an alternative pathway for the generation of oxidizing
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4185equivalents for disulphide formation in proteins entering the
secretory pathway. Such an alternative pathway has been
suggested to exist based upon the fact that, while Ero1
activity is essential in yeast, knockout of both Ero1 para-
logues in mice (Zito et al, 2010) or Ero1 in Drosophila (Tien
et al, 2008) does not cause a severe phenotype. In addition to
PrxIVrecycling, there are several other potential mechanisms
whereby PDI proteins may become oxidized independent of
Ero1. These include oxidation by the quiescin sulphydryl
oxidases (Chakravarthi et al, 2007; Rancy and Thorpe,
2008) or direct oxidation by H2O2 (Karala et al, 2009),
dehydroascorbate (Saaranen et al, 2010), oxidized vitamin
K (Wajih et al, 2007; Schulman et al, 2010) or glutathione
(GSH) disulphide (Appenzeller-Herzog et al, 2010). While
Ero1 can provide the oxidizing equivalents for disulphide
formation, the contribution of alternative pathways to oxida-
tive protein folding is still to be determined.
To determine whether there is a potential role for PrxIV in
disulphide formation, we tested the ability of several PDI-
family members to reduce peroxidatic disulphides and return
PrxIV to its peroxide reactive state. We demonstrate that PDI,
P5 and ERp46 can directly reduce PrxIV in vitro and can also
enhance recycling of peroxidatic disulphides within the ER of
mammalian cells. Indeed, PDI itself was oxidized more
efﬁciently by PrxIV than by Ero1a. In addition to establishing
the pathways for maintaining the catalytic activity of PrxIV,
these ﬁndings demonstrate an alternative mechanism for
oxidation of PDI and its homologues. Moreover, the coupling
by PrxIV of the reduction of H2O2 to the formation of a
disulphide ensures that two disulphides are formed for
every oxygen molecule reduced.
Results
PDI-family members reduce peroxidatic disulphides
in PrxIV
The overall oligomeric structure of PrxIV is a decamer con-
sisting of ﬁve dimers linked by interchain disulphide bonds
(Figure 1A, wild-type (WT)). PrxIV is a member of the 2-cys
family of peroxiredoxins, and therefore, has a reaction cycle
that involves conversion of a cysteine thiol to the sulpheny-
lated form following reaction with H2O2 (Wood et al, 2003).
The so-called peroxidatic cysteine (Cys124) then reacts with a
second cysteine residue, called the resolving cysteine
(Cys245), to form an interchain disulphide. As both polypep-
tides contain peroxidatic and resolving cysteines, two such
interchain disulphides can form. To follow this reaction, we
can separate the protein by SDS–PAGE under non-reducing
conditions and follow the formation or loss of multimeric
species (Figure 1B). However, the pattern of redox species is
complicated by the presence of the interchain disulphide
(Tavender et al, 2008), which forms between individual
Figure 1 Determining PrxIV redox status using SDS–PAGE. (A) Depiction of interchain disulphides formed within the wild-type (WT) PrxIV
decamer. For clarity, individual PrxIV molecules within each catalytic subunit are represented in different shades. Peroxidatic disulphides (solid
lines) form between PrxIV molecules within dimeric subunits and C51–C51 disulphides (dotted lines) link adjacent dimers. Also depicted are
disulphides formed within PrxIV cysteine to alanine mutants used in this study (C51A, DM and DM51). (B) Non-reducing SDS–PAGE analysis and
Coomassie blue staining of puriﬁed PrxIV showing electrophoretic behaviour of disulphide-linked forms in wild-type and C51A mutant PrxIV.
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2010b). The exact role of the non-catalytic disulphides is
unclear, although they are not necessary for peroxidase
activity of PrxIV (Supplementary Figure S1). The presence
of non-catalytic disulphides in puriﬁed PrxIV results in a
complex pattern of multimeric species, which affects the
interpretation of changes to the redox status of PrxIV using
a gel-based assay (Supplementary Figure S2). To simplify
changes to the redox status of PrxIV, we therefore use a PrxIV
C51A mutant (Figure 1, C51A) that lacks the ability to form
non-catalytic disulphides.
Puriﬁed recombinant PrxIV C51A exhibits a distinct mobi-
lity pattern when separated by SDS–PAGE carried out under
non-reducing conditions. The monomeric form migrates
close to the 25kDa marker, whereas two dimeric forms
migrate close to the 58kDa marker; the low-mobility dimer
corresponds to a single disulphide-bonded form, whereas the
high-mobility dimer corresponds to the double disulphide-
bonded form (Figure 1B). We have previously shown
(Tavender and Bulleid, 2010b) and show here that recombi-
nant PrxIV C51A puriﬁed under aerobic conditions predomi-
nantly contains two interchain disulphides (Figure 2C,
lane 1). Approximately 80% of the PrxIV contained two
disulphides, with the rest containing a single disulphide.
The puriﬁed PrxIV C51A therefore provides an ideal starting
material with which to measure factors capable of recycling
the protein to its reduced form.
To test the ability of ER-resident thioredoxin-like proteins
to reduce peroxidatic disulphides, we expressed and puriﬁed
several human PDI-family members, namely ERp46, P5, PDI,
ERp57 and ERp18 (Figure 2A). These PDI-family proteins
display variation in terms of size, domain architecture and
number of active sites (Figure 2B). PDI-family proteins were
prepared in a reduced state (Supplementary Figure S3), and
equimolar concentrations of each were incubated with PrxIV
C51A before the addition of TCA to quench thiol-disulphide
exchange. Equimolar concentrations were used because
quantiﬁcation of PrxIV levels in human HT1080 cells indi-
cated PrxIV to be present at comparable concentrations to
most of the oxidoreductases tested (Supplementary Figure
S4). In addition, we tested the ability of GSH at physiological
concentration to reduce puriﬁed PrxIV C51A (Figure 2C and D).
Strikingly, both ERp46 and PDI reduced PrxIV more rapidly
and more extensively than GSH during the brief incubation
period. ERp46 almost completely removed the high-mobility
dimer and accumulated around 70% of the total PrxIV in a
fully reduced form within the ﬁrst minute. P5 and ERp57 also
served as effective reductases, initially reducing PrxIV C51A
in a comparable manner to GSH but eventually accumulating
a higher proportion of fully reduced material (Figure 2D),
indicating that equimolar quantities of either protein can
reduce peroxidatic disulphides at least as effectively as a
3300-fold excess of GSH. In contrast, ERp18 had a negligible
effect generating barely perceptible quantities of fully re-
duced PrxIV (o10%). These results clearly show that the
PDI family of oxidoreductases have speciﬁcity in their ability
to reduce the peroxidatic disulphides in PrxIV.
Reduction of PrxIV results in oxidation of ER
oxidoreductases
Reduction of PrxIV by a PDI-family member implies the
occurrence of a thiol-disulphide exchange reaction between
the two proteins. In this case, reduction of PrxIV should result
in oxidation of the PDI-family member. To test this, we
took samples of each ER oxidoreductase that had been
incubated for 3min with PrxIV C51A (samples are shown in
Figure 2C, lane 7). Following TCA precipitation, proteins
were re-suspended in a denaturing buffer containing the
sulphydryl-modifying agent 4-acetamido-40-maleimidylstilbene-
2,20-disulphonic acid (AMS). AMS reacts with thiol groups,
increasing the molecular weight of the protein and retarding
electrophoretic mobility. A protein with oxidized cysteine
residues lacks free thiols. Hence, it is not modiﬁed by AMS
and therefore migrates more rapidly than a protein with
reduced cysteines (Supplementary Figure S3). Following in-
cubation with PrxIVa clear decrease in AMS-modiﬁed protein
was observed for ERp46, P5, PDI and ERp57 (Figure 3A and B),
indicating substantial oxidation of cysteine residues in each
protein. ERp18 remains predominantly reduced and therefore
AMS modiﬁed. The small population of ERp18 that does
become oxidized is attributable to the aforementioned reduc-
tion of up to 10% of PrxIV C51A. Thus, the recycling of the
catalytic thiols of PrxIV by ERp46, PDI, P5 or ERp57 occurs
concomitant with the oxidation of these proteins.
GSH enhances PrxIV recycling by reducing PDI-family
members
A role for GSH in maintaining ER oxidoreductases in a
reduced state has been highlighted previously (Jessop and
Bulleid, 2004). Addition of GSH to a reaction mixture contain-
ing PrxIV C51A and P5 resulted in complete reduction of
peroxidatic disulphides within 2min (Figure 4A). This reduc-
tion is in stark contrast with incubations lacking GSH where
one third of total PrxIV is typically fully reduced. The
complete reduction of peroxidatic disulphides observed
with a combination of P5 and GSH suggests more than simply
a cumulative effect of the reductants, as individually they
only reduce PrxIV by B30 and 20%, respectively. When the
redox state of P5 was assayed following incubation with
PrxIV C51A and GSH, it was found to be completely reduced
(Figure 4A, lane 3, lower panel). It therefore appears that
GSH maintains P5 in a reduced state during incubation with
PrxIV. In a similar manner, inclusion of GSH in reactions
containing PrxIV C51A and ERp46 led to ERp46 remaining
more reduced than in the absence of GSH (Figure 4B, bottom
panel). Control samples of P5 or ERp46 incubated in buffer
alone (Figure 4A and B, lane 4) remained reduced demon-
strating that neither protein is oxidized in the absence of
PrxIV during the incubation period.
Unlike the situation with P5, GSH addition did not enhance
peroxidatic disulphide reduction by ERp46, simply because
PrxIV C51A was fully reduced within the 2-min incubation
even in the absence of GSH. However, an effect on the redox
status of ERp46 was observed, which may indicate that GSH
augments the efﬁcacy of PrxIV recycling by ERp46. When
analysed by Coomassie blue stain, a small amount of high
molecular weight material was consistently visible during
reduction of PrxIV C51A by ERp46 (Figure 4B, indicated with
arrow). Whether this material consists of protein aggregates
or intermediate complexes of PrxIV and ERp46 is unclear.
Whatever the nature of this species, its appearance was
curtailed by inclusion of GSH.
In a similar manner to that observed for P5, addition of
GSH to a reaction mixture containing PrxIV C51A and PDI
Redox exchange between PrxIV and PDI proteins
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(Figure 4C). Within these reactions, the redox condition of
each PDI active site could be quantitatively determined
(Figure 4D) using a recently described differential alkylation
and mass spectrometry approach (Chambers et al, 2010).
Using this methodology, we demonstrated that about 65%
of the active sites within PDI became oxidized within 2min
when incubated with PrxIV in the absence of GSH. This
extent of PDI oxidation correlates with the extent of reduction
of PrxIV (B60%, Figure 2D). In the presence of GSH, both
active sites of PDI remain in the reduced form. Intriguingly, it
was also clear that in the absence of GSH, reduction of PrxIV
results in the preferential oxidation of the PDI a’ domain
(Figure 2D). Such an effect has been demonstrated previously
during the oxidation of PDI by Ero1a (Chambers et al, 2010).
The reduction of peroxidatic disulphides could be mediated
Figure 2 PDI-family members can reduce PrxIV peroxidatic disulphides in vitro.( A) SDS–PAGE analysis (reducing conditions) and Coomassie
blue staining of puriﬁed proteins prepared for use in this study. An ERp46 degradation product is indicated (*). (B) Simple representation of
domain architecture for PDI-family members used in this study. Catalytically active thioredoxin-like domains with CXXC motifs are depicted as
black boxes, while grey boxes indicate inactive thioredoxin-like domains. (C) Fluorescent western blots showing disulphide-bonded status of
puriﬁed PrxIV C51A (3mM) during incubation with 10mM GSH or 3mM reduced PDI-family member. Reactions were quenched with TCA and
precipitated proteins were re-dissolved in the presence of NEM before non-reducing SDS–PAGE and blotting with antibody to PrxIV. PrxIV
dimers containing two disulphides (2 S–S) or one disulphide (1 S–S) as well as fully reduced PrxIV (0 S–S) are indicated. (D) Western
blots were used for quantiﬁcation of fully reduced PrxIV C51A by densitometry. Intensity of fully reduced form is expressed as a proportion of
the sum total intensity of 0 S–S, 1 S–S and 2 S–S fractions. Data presented are representative experiments performed at least three times
with similar results.
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the a domain via PDI intramolecular exchange as has been
suggested for the reaction with Ero1a (Chambers et al, 2010).
Increased expression of PDI-family proteins enhances
PrxIV recycling in the ER
Having demonstrated that ERp46, PDI, P5 and ERp57 can
directly reduce peroxidatic disulphides of PrxIV in vitro,w e
set out to determine if they could exert an inﬂuence over this
process within the ER. For these experiments, we used a
HT1080 cell line stably overexpressing PrxIV C51A. The
intracellular form of this protein exists as a mixture of
oxidized and reduced species (Figure 5A, side panel)
(Tavender and Bulleid, 2010b). When the cytosol from this
cell line was removed by digitonin permeabilization of the
plasma membrane, PrxIV C51A becomes nearly completely
oxidized (Figure 5A, lane 1). Hence, during the preparation of
semipermeabilized (SP) cells, factors required for maintain-
ing reducing pathways within the ER are removed. We have
shown previously that a reducing pathway can be re-estab-
lished by addition of GSH to SP cells resulting in re-equilibra-
tion of the PrxIV redox status to reﬂect that seen for intact
cells (Tavender and Bulleid, 2010b).
To demonstrate the kinetics of GSH-dependent reduction of
PrxIV C51A in SP cells, GSH was added to a ﬁnal concentra-
tion of 10mM, and at various time points, the redox status of
PrxIVwas frozen by the addition of the membrane-permeable
thiol-alkylating agent N-ethylmaleimide (NEM) (Figure 5A,
top panel). During the time course, a shift from high-mobility
to low-mobility dimer was evident along with the appearance
of some fully reduced PrxIV. It is unclear whether reduction
of peroxidatic disulphides in PrxIV involves direct reduction
by GSH or is caused by GSH ﬁrst reducing endogenous ER
oxidoreductases necessary for recycling PrxIV. If the reduc-
tion of peroxidatic disulphides in the ER relies principally
upon an enzymatic process, we hypothesized that increasing
the concentration of relevant oxidoreductases in the ER
would enhance the rate of GSH-initiated reduction of PrxIV.
Consequently, SP cells were prepared using HT1080 PrxIV
C51A cells that had been transfected to transiently overex-
press ERp46, P5, PDI, ERp57 or ERp18 (Figure 5B). Ectopic
expression was typically between 4- and 10-fold higher than
endogenous levels although this could not be accurately
determined for ERp18 on account of our inability to detect
the endogenous protein.
The increase in concentration of ERp46, P5 and PDI each
caused an enhanced recovery of reduced PrxIV C51A follow-
ing the addition of GSH to SP cells (Figure 5A and C). The
differences between these treatments and untransfected cells
are best visualized by comparing the relative proportions of
each PrxIV species at 2 and 4min following GSH addition
(Figure 5A). Despite exhibiting reductase activity towards
PrxIV disulphides in vitro, elevated concentrations of ERp57
displayed no discernible effect upon reduction of PrxIV C51A
in SP cells. This lack of effect is perhaps not surprising given
that ERp57 interacts with calnexin and calreticulin (Oliver
et al, 1997) and, therefore, is unlikely to act on non-glyco-
protein clients such as PrxIV. The fact that ERp57 does not
enhance PrxIV reduction in the ER therefore suggests that
ERp57 may be adequately sequestered by calnexin or calre-
ticulin even when ERp57 is overexpressed. Overexpression of
ERp18 also failed to increase the appearance of fully reduced
PrxIV C51A, which is again not surprising considering
the negligible activity of ERp18 as a reductase of PrxIV
Figure 3 PDI-family members are oxidized by PrxIV C51A in vitro.( A) AMS-dependent changes in electrophoretic mobility of puriﬁed reduced
PDI-family members following incubation of each protein with equimolar oxidized PrxIV C51A. Reactions were quenched by TCA addition and
precipitated proteins were re-dissolved in denaturing buffer containing AMS. Proteins were visualized by SDS–PAGE (reducing conditions) and
Coomassie blue staining. (B) Densitometry proﬁles of stained bands for each gel-lane displayed in (A) illustrating relative electrophoretic
mobilities.‘Zero’ distance value of graphs relates to bottom end of each lane. Relationship between gel position and relative free thiol content is
indicated (black triangle).
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that in the mammalian ER, ERp46, P5 and PDI can catalyse
the reduction of the peroxidatic disulphides within PrxIV.
Mixed disulphides indicate direct reduction of
peroxidatic disulphides by PDI-family members
in the ER
To establish that ERp46, P5 and PDI act directly on PrxIV, we
investigated whether we could trap mixed disulphides that
should form during the disulphide exchange reaction. The
reduction of disulphides by PDI-family members requires the
nucleophilic attack on a disulphide by the ﬁrst cysteine
residue of the conserved CXXC motif. A transient mixed
disulphide is formed between the oxidoreductase and the
target molecule, which is rapidly resolved by the second
cysteine residue of the CXXC motif. Trapping of mixed
disulphides is facilitated by cysteine to alanine mutation to
modify the CXXC motif to CXXA. Without the second cy-
steine, resolution of the mixed disulphide is dependent on an
alternative thiol source, substantially increasing the lifespan
of this normally short-lived intermediate (Dick and Cresswell,
2002).
We have previously created a range of HT1080 cell lines
stably expressing PDI-family CXXA mutants and used these to
identify PrxIV as one of the predominant endogenous pro-
teins forming mixed disulphides with ERp46 in HT1080 cells
(Jessop et al, 2009b). Likewise, when translated in vitro in
the presence of SP cells produced from these cell lines,
Figure 4 Glutathione reduces PDI-family members and enhances peroxidatic recycling. Puriﬁed PrxIV C51A (6mM) was incubated with
equimolar reduced P5 (A) or ERp46 (B) in the presence and absence of 10mM GSH. Reactions were split in two and quenched by TCA addition.
One sample for each treatment was precipitated, re-dissolved in SDS sample buffer containing NEM and analysed by non-reducing SDS–PAGE
and Coomassie staining (top panel). The second sample for each was re-dissolved in denaturing buffer containing AMS and visualized by
Coomassie blue staining following SDS–PAGE under reducing conditions (bottom panel). Lane 4 contains reduced P5 or ERp46 incubated alone
for 2min and modiﬁed with AMS as above. An arrow indicates high molecular weight material observed for ERp46 and an asterisk (*)
demarcates the ERp46 degradation product. (C) PrxIV C51A (4mM) was incubated with equimolar reduced PDI plus or minus 10mM GSH. Four
replicates were prepared for each reaction and quenched by TCA addition. One replicate was precipitated, re-dissolved in SDS sample buffer
containing NEM and analysed by non-reducing SDS–PAGE and western blotted with antibody to PrxIV. Remaining replicates were re-dissolved
in denaturing buffer containing iodoacetic acid, separated using non-reducing SDS–PAGE and PDI excised and prepared for MALDI-TOF
analysis of redox status as detailed in Chambers et al (2010). For a and a’ domains of PDI, the proportion of active sites recorded as being
reduced are expressed as a fraction of the whole population (D). Values are mean averages of triplicates with error bars representing s.d.
A schematic depicting the positions of the a and a’ domains of PDI is included.
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phides with ERp46 and P5. In each case, the native PrxIV
sequence was translated, potentially containing both
peroxidatic disulphides and non-catalytic disulphides.
Consequently, it was not possible to conclude whether
the mixed disulphides were formed during the nucleophilic
Figure 5 Increased PDI-family expression enhances peroxidatic recycling in SP cells. (A) Non-reducing SDS–PAGE and anti-PrxIVwestern blot
analysis. SP cells were prepared from HT1080 PrxIV C51A cells transiently transfected to overexpress ER oxidoreductases (as indicated) or
without DNA (UT). Following incubation with 10mM GSH, SP cells were treated with NEM, harvested and lysed. The side panel for sample
‘UT’ shows a similar anti-PrxIV western blot for intact HT1080 PrxIV C51A cells treated with NEM prior to lysis. (B) SP cells prepared in (A)
were used to determine oxidoreductase content by ﬂuorescent western blotting. Samples transfected with PDI-family constructs (þ) were
probed alongside control samples (UT) ﬁrst with the relevant anti-PDI-family antibody, then stripped and probed with anticalreticulin (Crt).
Samples presented within each individual panel are from the same gel. Anti-Crt panels presented are from the same gel as the corresponding
anti-PDI-family blot. Intensities for oxidoreductase samples were calculated by densitometry and adjusted to reﬂect Crt values. Intensities for
control samples were taken as 100% and levels of overexpression for transfected cells given relative to this. Values are mean averages of
triplicate quantiﬁcations±s.d. Endogenous ERp18 was not detected although intensity values for transfectants indicated at least 1000%
increased expression. Ectopically expressed proteins exhibit some altered mobility due to epitope tags. (C) Appearance of fully reduced PrxIV
for blots as in (A) was quantiﬁed as in Figure 2D.
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or on non-catalytic disulphides within PrxIV. To address this
issue, a similar experiment was undertaken using PrxIV
cysteine to alanine mutants, which could only form one of
the two species of disulphide. SP cells were prepared from
HT1080 cell lines stably expressing V5-tagged ERp46, P5, PDI
or ERp57 in which all active site CXXC motifs were mutated
to CXXA. The SP cells were then added to in vitro translation
reactions with mRNA encoding one of four PrxIV variants
(depicted in Figure 1A). C51A cannot form the non-catalytic
disulphide, DM cannot form the peroxidatic disulphide and
DM51 cannot form any disulphides. Once the incubation was
complete, thiol-disulphide exchange was inhibited with NEM,
SP cells were harvested and V5-tagged PDI-family members
were immunoisolated along with any covalently linked mixed
disulphide partners (Figure 6). The CXXA mutants of ERp46,
P5 and PDI accumulated mixed disulphides more readily with
PrxIV C51A (i.e. via nucleophilic attack of the peroxidatic
disulphide) than with PrxIV DM (Figure 6, compare lanes 2
and 3 for all samples). In keeping with the apparent lack of
ERp57 activity towards PrxIV C51A in the ER, ERp57 failed to
form signiﬁcant mixed disulphides with PrxIV (Figure 6,
bottom right). These results demonstrate that ERp46, P5
and PDI but not ERp57 can directly reduce the peroxidatic
disulphides in PrxIV within the ER.
Lowering the intracellular concentration of ER
oxidoreductases compromises reduction of PrxIV
From the above results, it is clear that at least three members
of the PDI family of ER oxidoreductases are capable of
directly reducing the peroxidatic disulphides in PrxIV. It is
not apparent whether these enzymes have overlapping func-
tions or whether one enzyme preferentially reduces PrxIV in
the ER. To address this question, we used shRNA treatment of
the PrxIV C51A overexpressing cell line to lower the levels of
ERp46, P5 or PDI either individually or in combination.
Quantiﬁcation of the levels of these proteins following treat-
ment of cells with shRNA revealed knockdowns to between
20 and 50% of normal levels (Figure 7A). The consequence of
this knockdown on the reduction of ER PrxIV C51A in the
presence of GSH was then determined using the SP-cell assay
(Figure 7B and C). In comparison to control cells that had
been treated with a non-speciﬁc shRNA, the rate of reduction
of PrxIV C51A was compromised with each individual
shRNA. A modest slowing of the rate was seen with the
PDI shRNA-treated cells with a more dramatic effect seen
with the shRNA constructs targeting ERp46 and P5. In addi-
tion, the rate of recovery of reduced PrxIV C51A with cells
treated with ERp46 shRNA in combination with P5 or PDI
shRNA was severely perturbed (Figure 7B and C). Such a
dramatic effect following the lowering of the levels of these
Figure 6 Substrate-trapping PDI-family mutants target peroxidatic disulphides in PrxIV. SP cells prepared from HT1080 cell lines expressing
substrate-trapping PDI-family CXXA mutants were added to an in vitro translation system. Wild-type (WT) or mutant (C51A, DM, DM51) PrxIV
was translated and radioactively labelled, treated with NEM and SP cells harvested. One ﬁfth of cells were lysed directly with SDS sample buffer
for analysis of total translation products (top panels for each set). Remaining cells were used for anti-V5 immunoisolation of PDI-family
mutants along with any trapped substrate. PrxIVwas visualized by SDS–PAGE (reducing conditions) and phosphorimaging. PrxIV isolated with
each PDI-family mutant was measured by densitometry and is expressed as a percentage of the total translated product forming a mixed
disulphide.‘pPrxIV’ indicates full-length preprotein, whereas ‘PrxIV’ indicates protein that has been translocated to the ER and had the signal
peptide removed. Samples are representative of repeat experiments.
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of recycling of PrxIV. These results further support the
hypothesis that ERp46, P5 and PDI are required to maintain
PrxIV in an enzymatically active form.
Discussion
The concept that Ero1 is the sole source of oxidizing equiva-
lents for disulphide formation in proteins entering the secre-
tory pathway has recently been questioned due to a lack of a
dramatic phenotype when both Ero1 paralogues are deleted
in mice (Zito et al, 2010). Several additional pathways have
been suggested to compensate for a lack of Ero1 (Margittai
and Banhegyi, 2010), though their relevant contribution to
disulphide formation remains to be established. Here, we
have demonstrated that the oxidation of members of the ER
oxidoreductase family by PrxIV is a robust and efﬁcient
mechanism to provide oxidizing equivalents for these
Figure 7 Decreased PDI-family expression compromises peroxidatic recycling in SP cells. (A) HT1080 PrxIV C51A cells were transfected with
shRNA to PDI-family member as indicated or control shRNA (shGFP). After selection for the shRNA-expressing population, SP cells were
prepared and analysed by SDS–PAGE (reducing conditions) and ﬂuorescent western blotting. Blots were probed with relevant antibodies
against ER oxidoreductases then stripped and probed with anti-Crt. Intensities of oxidoreductase bands were calculated by densitometry and
adjusted to reﬂect loading controls. Values for shGFP samples were taken as 100% and knockdown of ER oxidoreductase expression calculated
relative to this. Values are mean averages of triplicate quantiﬁcations±s.d. (B) SP cells generated above were incubated with 10mM GSH as
indicated then treated with 40mM NEM. Cells were harvested, lysed and subjected to non-reducing SDS–PAGE analysis prior to western
blotting with antibody to PrxIV. (C) Appearance of fully reduced PrxIV was quantiﬁed as in Figure 2D.
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with oxygen, H2O2, is used as the electron acceptor during
disulphide formation in PrxIV meaning that the combination
of reduction of oxygen by Ero1 and PrxIV results in the
oxidation of two molecules of ER oxidoreductase. Coupling
these two enzymes together will result in a much more
efﬁcient oxidative pathway and may go some way to explain
why the oxidation of PDI by Ero1 in vitro is a relatively
inefﬁcient process (Sevier et al, 2007; Baker et al, 2008;
Chambers et al, 2010). Such a pathway for disulphide forma-
tion via PrxIV is not exclusively dependent upon Ero1 as
there are other enzymes, which can generate H2O2 in the ER.
These include the NADPH oxidase Nox4 (Van Buul et al,
2005) and the quiescin sulphydryl oxidase (Hoober et al,
1999). In addition, H2O2 produced by the mitochondria could
also potentially enter the ER due to the close association of
these two organelles (Simmen et al, 2010). Hence, in the
absence of Ero1, PrxIV could fuel disulphide formation by
providing the necessary oxidizing equivalents. It is of interest
to note that yeast do not contain an equivalent ER-localized
peroxiredoxin and that, unlike in mammals, Ero1p in yeast is
an essential gene (Frand and Kaiser, 1998; Pollard et al,
1998).
Comparing the relative efﬁciencies of Ero1 and PrxIV in
oxidizing ER oxidoreductases could provide some indication
as to the relative contribution of each pathway to disulphide
formation. When the physiological concentrations of the
components are taken into account, then the oxidation of
PDI by PrxIV seems much more efﬁcient than that by Ero1a.
PDI and PrxIVare present in the ER of HT1080 cells at roughly
equivalent concentrations, whereas Ero1a is a relatively low
abundance protein (Gess et al, 2003). About 20% of the PDI
active sites become oxidized by Ero1a after 30min incubation
when combined in a ratio of 1:25 (Chambers et al, 2010).
In comparison, 60% of the PDI active sites were oxidized by
PrxIV within 2min when incubated at a ratio of 1:1. Ideally,
we would have liked to couple the activity of the two
enzymes in vitro to oxidize PDI, but the inability to maintain
reduced PrxIV for subsequent reaction in aerobic buffers
precluded this approach. Indeed, it is the exquisite sensitivity
of PrxIV to oxidation by low concentrations of H2O2 that
would provide an extremely efﬁcient mechanism to convert
any H2O2 produced in the ER into disulphides.
During the course of this study, we consistently found that
ERp46 and P5 were more efﬁciently oxidized by PrxIV than
PDI. In addition, all three ER oxidoreductases were oxidized
to a greater extent than GSH by PrxIV. However, when
GSH was included in the incubations, the oxidoreductases
were completely reduced. In addition, the presence of GSH
increased the rate of reduction of PrxIV by P5 and PDI and
prevented the formation of high molecular weight aggregates.
Together, these results suggest that the ER oxidoreductases
ﬁrst reduce the peroxidatic disulphide in PrxIV and are then
reduced by GSH. Given that the ER oxidoreductases are
predominantly in a reduced form (Jessop and Bulleid,
2004), these results suggest that any disulphide formed with-
in these enzymes is rapidly exchanged with either substrate
proteins, or with GSH to form GSSG. Indeed, recent work
looking at the Ero1a-dependent recovery of cells from treat-
ment with the reducing agent DTTshows an initial increase in
the GSSG concentration, suggesting that the ultimate target
for disulphide exchange under these conditions is GSH
(Appenzeller-Herzog et al, 2010). The concentration of
GSSG then recovers to lower levels, indicating that GSSG is
either used for disulphide formation in newly synthesized
proteins or is reduced by an as yet unidentiﬁed reduction
pathway. The fact that GSH efﬁciently reduces the ER oxidor-
eductases suggests that GSSG may well be a major source of
disulphides for newly synthesized proteins.
ERp46 outperformed P5 and PDI in the ability to reduce
PrxIV in vitro and in the formation of mixed disulphides with
PrxIV species in SP cells. Moreover, both elevation and
knockdown of ERp46 substantially inﬂuenced reduction of
PrxIV in the ER. ERp46 may therefore be a preferred substrate
for thiol-disulphide exchange with PrxIV. The preferential
oxidation of ERp46 by PrxIV could be due to the presence
of three rather than two active thioredoxin domains in this
protein. ERp46 has been previously described as endoPDI due
to its upregulation in endothelial cells, where it can act as a
stress survival factor (Sullivan et al, 2003). In addition, it is
upregulated along with a number of other ER oxidoreductases
as well as PrxIV in differentiating B cells (van Anken et al,
2003). These previous studies are consistent with a role for
ERp46 in regulating ER redox balance.
Such a role for ER oxidoreductases would be distinct from,
or in addition to, their role in disulphide formation in
proteins entering the secretory pathway. The study of the
roles for the individual ER oxidoreductases in the past has
focused on the idea that each may act as an oxidase or
reductase on speciﬁc substrates. The association of individual
oxidoreductases with ER chaperones, such as ERp57 with the
calnexin/calreticulin cycle (Oliver et al, 1997; Jessop et al,
2009a) and P5 with BiP (Meunier et al, 2002; Jessop et al,
2009b), indicates speciﬁc roles for these enzymes on subsets
of proteins and to some extent may explain substrate speci-
ﬁcity. Further dissection of the mechanisms of speciﬁcity for
P5 and ERp46 are essential for full understanding of their
individual roles in recycling PrxIV. The fact that we show
only limited speciﬁcity of ER oxidoreductases towards PrxIV
would suggest that some of these proteins may also act as a
conduit for oxidizing equivalents to produce GSSG rather
than acting directly with client proteins. As each of these
proteins is present at signiﬁcant concentrations in the ER,
their ability to transfer disulphides between H2O2 and GSH
would establish an efﬁcient redox buffer to balance the ER
redox status.
It is now well established that the activity of Ero1a is
tightly regulated by the presence of non-catalytic disulphides
that need to be reduced to activate the enzyme (Tavender and
Bulleid, 2010a). As PrxIV is able to very efﬁciently react with
any H2O2 produced in the ER, is there a requirement to
regulate the activity of PrxIV? Other cellular peroxiredoxins
can be inhibited in the presence of high concentrations of
H2O2 by the over oxidation of the peroxidatic cysteine residue
to form sulphinic or sulphonic derivatives (Woo et al, 2003).
The expression of a deregulated mutant of Ero1a results in a
marked increase in the concentration of GSSG in the ER
(Appenzeller-Herzog et al, 2008), and results in the formation
of over oxidized PrxIV (Tavender and Bulleid, 2010b). In
addition, treating cells with DTTcauses a rapid over oxidation
of PrxIV presumably due to an acute increase in H2O2 caused
by a rapid reduction of the regulatory disulphides in Ero1a
and in substrate proteins. Hence, it may well be the case that,
under certain stress conditions, PrxIV becomes over oxidized
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act as a signal for ER oxidative stress.
There are potentially several mechanisms for maintaining
a redox balance and preventing oxidant build-up in the ER
(Gorlach et al, 2006), so it is possibly not surprising that the
mouse knockout of PrxIV, like the Ero1a knockouts, is still
viable with the only notable phenotype being an effect on
testicular morphology (Iuchi et al, 2009). The lack of broad
effects of PrxIV knockout upon mouse physiology indicates
that a robust antioxidant defence remains even in the absence
of PrxIV. This may be consistent with PrxIV—like Ero1—
forming one of several integrated systems to facilitate
disulphide formation and to regulate ER redox homeostasis.
Materials and methods
Reagents and antibodies
All reagents were acquired from Sigma-Aldrich (Dorset, UK) and
enzymes were acquired from Promega (Southampton, UK) unless
otherwise stated. Rabbit polyclonal anti-PrxIV was purchased from
Ab Frontier (Seoul, Korea), rabbit polyclonal anti-calreticulin was
purchased from Stressgen (Exeter, UK) and rabbit polyclonal anti-
ERp46 was purchased from AbCam (Cambridge, UK). Rabbit
polyclonal antibodies raised against PDI, P5 and ERp57 have been
described previously (Jessop and Bulleid, 2004), while puriﬁed
protein prepared for this study was used to raise a rabbit polyclonal
antibody to ERp18. Mouse monoclonal anti-V5 was obtained from
Invitrogen (Paisley, UK).
Preparation of puriﬁed proteins
All proteins (minus secretory signal peptides) were expressed and
puriﬁed using Escherichia coli BL21-DE3. His-tagged PrxIV puriﬁca-
tion has been described previously (Tavender and Bulleid, 2010b),
and ERp18 was cloned into pRSFDuet-1 (Novagen, Nottingham,
UK) for His-tagged protein puriﬁcation in an identical manner.
His-tagged PDI was similarly expressed and puriﬁed by Ni
2þ
column chromatography as described previously (Baker et al, 2008)
as was His-tagged ERp57, following expression from a plasmid
kindly donated by Stephen High (University of Manchester, UK),
and His-tagged P5 following cloning into pET21a(þ) (Novagen). A
construct expressing a GST-ERp46 fusion protein was a kind gift
from David Thomas (McGill University, Montreal, Canada). GST-
ERp46 was expressed for 4h using 0.5mM IPTG induction, bound
to GSH-sepharose (GE Healthcare, Buckinghamshire, UK) by
standard batch puriﬁcation and ERp46 eluted by on-column
cleavage with precision protease (GE Healthcare) in accordance
with the manufacturer’s instructions. Proteins were reduced by
incubation with 5mM DTT for 15min at room temperature then
DTT removed by buffer exchange into reaction buffer (50mM
NaH2PO4, 150mM NaCl, 1mM EDTA, pH 7.4) using a PD10 column
or Superdex 200 gel ﬁltration column (both GE Healthcare). Each
protein was quantiﬁed using the relevant 280nm absorption
extinction coefﬁcient.
Reduction of PrxIV in vitro
PrxIV and ER oxidoreductases were incubated in reaction buffer at
371C at the concentrations and time periods indicated in the text.
Where required, GSH was added from a 10  stock (dissolved in
reaction buffer and adjusted to pH 7 with NaOH). Reactions were
quenched by addition of four volumes of 12.5% w/v TCA in H2O,
incubated on ice for 15min and precipitated proteins pelleted by
centrifugation for 15min at 15000g,4 1C. Pellets were vortexed to
re-suspend in ice-cold acetone and pelleted again for 5min.
Following a repeat acetone wash pellets were air dried for 15min
and re-suspended in either SDS sample buffer (31.25mM Tris–HCl
pH 6.8, 2% w/v SDS, 5% v/v glycerol, 0.01% w/v bromophenol
blue) containing 40mM NEM or alkylation buffer (200mM Tris–HCl
pH 8, 0.5% SDS, 6M urea) containing 10mM AMS or 50mM IAA as
appropriate. In the case of SDS sample buffer plus NEM, samples
were vortexed and immediately heated at 1001C for 5min. For
alkylation buffer plus AMS/IAA, samples were incubated for 30min
in the dark at room temperature then 0.25 volumes of 5 SDS
sample buffer added and boiled as above.
Mass spectrometry determination of PDI redox condition
This analysis was performed exactly as recently described
(Chambers et al, 2010).
GSH-dependent reduction of PrxIV in SP cells
Where required, cells were initially transfected with recombinant
DNA to modulate ER oxidoreductase levels. For overexpression,
cells were seeded to 60% conﬂuence in 15cm cell culture dishes
and transfected with 12mg plasmid DNA encoding the appropriate
V5-tagged PDI-family member (construct creation described else-
where (Jessop et al, 2009b)). Transfection was performed using
polyethylenimine exactly as established previously (Gleghorn et al,
2010), with volumes increased three-fold to reﬂect increased
quantity of DNA. Cells were harvested for SP-cell preparation at
48h post-transfection. For knockdown of PDI-family expression,
cells were transfected as above using DNA constructs encoding
shRNA against the relevant PDI-family members (Origene, Rock-
ville, MD, USA). At 16h post-transfection, puromycin selection
(1mg/ml) was introduced to remove cells not expressing shRNA and
maintained for a further 4–5 days before preparation of SP cells. SP
cells were prepared as detailed previously (Wilson et al, 1995) and
suspended in KHM buffer (110mM potassium acetate, 20mM
HEPES, 2mM magnesium acetate, pH 7.2 with KOH) at a ﬁnal
concentration of 10
7 SP cells/ml. For protein expression controls,
samples containing 3 10
5 SP cells were immediately transferred to
ice. GSH was added to remaining suspension from a 10  stock
(dissolved in KHM buffer and adjusted to pH 7 with NaOH) and
incubated at 371C. At required times, samples containing 3 10
5 SP
cells were removed to ice and NEM added to 40mM ﬁnal
concentration. After a minimum of 5min, nine volumes of KHM
were added and cells were pelleted by centrifugation for 2min at
4000g. Supernatants were removed and cells were lysed by addition
of 30ml SDS sample buffer and heated at 1001C for 5min.
Trapping mixed disulphides with PrxIV translated in vitro
PrxIV translation and translocation into SP cells was performed
essentially as described previously (Tavender et al, 2008). RNA
transcripts were prepared by T7 transcription from XhoI linearized
pcDNA3.1/hygro(þ) constructs encoding PrxIVor mutants thereof.
Following translation for 1h at 301C, cells were treated with 40mM
NEM for 5min on ice then diluted with nine volumes of ice-cold
KHM buffer. One ﬁfth of suspension was centrifuged for 1min at
10000g, supernatant was removed and SP cells were lysed in SDS
sample buffer for analysis of total translation products. Remaining
suspension was centrifuged as above, supernatant was removed
and cells were lysed by vortexing with 50ml IP buffer (50mM Tris–
HCl, 150mM NaCl, 2mM EDTA, 0.5mM PMSF, 1% v/v Triton X-
100). Lysates were clariﬁed by centrifugation for 2min at 16000g
and supernatant was mixed with 10% w/v SDS for ﬁnal
concentration 1% w/v SDS. After 3min at 1001C, samples were
diluted to 1.2ml with IP buffer and incubated with 50ml 10% w/v
Protein A sepharose (PAS) for 30min at 41C with rotation. PAS was
removed by centrifugation for 1min at 16000g and supernatants
were mixed with 50ml fresh PAS and 1ml anti-V5 antibody before
incubation for 16h at 41C with rotation. PAS was harvested by
centrifugation as above, and supernatants were discarded. PAS was
washed three times with IP buffer and bound proteins were released
by addition of SDS sample buffer and heating at 1001C for 5min.
Electrophoresis, western blotting and densitometry
For Coomassie blue staining of puriﬁed proteins, 2–4mg of protein
was typically loaded. For western blot analysis, 400ng was used.
For western blots of SP-cell lysates, an equivalent of 10
5 cells were
used per sample under reducing conditions, 1.5 10
5 cells under
non-reducing conditions. For SDS–PAGE under reducing conditions,
DTT was added to samples at 50mM concentration before boiling,
for non-reducing conditions DTT was omitted. Gels were stained
overnight using colloidal Coomassie blue (10% w/v phosphoric
acid, 10% w/v ammonium sulphate, 0.12% Coomassie brilliant
blue G250, 20% v/v methanol) followed by destain in distilled
water or were transferred to nitrocellulose for western blotting. Due
to problems with high background observed using alternative
western blotting protocols, non-reducing anti-PrxIV blots of SP cell
derived material were performed exactly as described previously
(Tavender et al, 2008). For all other samples, a system was used
incorporating ﬂuorescent secondary antibodies. For ﬂuorescent
western blots, proteins were transferred to Odyssey nitrocellulose
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standard Protran membrane (Whatman, UK) was used. Blocking
and primary antibody incubations for ﬂuorescent blots were as
previously detailed (Tavender et al, 2008). Secondary antibody
differed only in dilution factor (1 in 2500) and in being performed in
a light-shielded box. Following ﬁnal wash steps, blots were scanned
using an Odyssey SA imaging system (Li-Cor Biosciences). For
quantiﬁcation of ﬂuorescent western blots, scans were performed at
minimum intensities required to visualize all relevant species.
Densitometry was then performed upon unmodiﬁed output images
using ImageJ (NIH, USA). For traditional blots, multiple exposures
were performed and blots were selected in which samples exhibited
a linear response to the chemiluminescent substrate. Band
intensities were again quantiﬁed using ImageJ. In all cases,
identical sized boxes were used for all protein samples within a
given blot and a local background also subtracted for each
individual sample. Due to the absence of cytosolic proteins, Crt
was used as a loading control for quantiﬁcation of SP-cell protein
content. During initial experiments, samples were ﬁrst probed with
anti-Crt, then western blot membranes stained using amido-black to
visualize total protein. Crt levels were reliably unaffected by
modulation of PDI-family expression and therefore suitable as a
reference standard. Where required, bound antibodies were
stripped from nitrocellulose membranes by 2 5min washes in
0.2M NaOH followed by 5min in distilled water. Primary antibodies
were then re-applied without the need for further blocking.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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